Page last updated: 2024-09-03

elacridar and Brain Stem Neoplasms

elacridar has been researched along with Brain Stem Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becher, OJ; Chung, AH; Crabtree, D; Elmquist, WF; Halvorson, KG; Hu, G; Mittapalli, RK; Parrish, KE1

Other Studies

1 other study(ies) available for elacridar and Brain Stem Neoplasms

ArticleYear
ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:5

    Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Brain Stem Neoplasms; Cell Line, Tumor; Dasatinib; Disease Models, Animal; Drug Synergism; Gene Expression; Glioma; Humans; Mice; Mice, Knockout; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Tetrahydroisoquinolines; Treatment Outcome; Xenograft Model Antitumor Assays

2016